Holen Sie sich die Stockscreener-App
97.08
0.37%
-0.36
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$97.44
Offen:
$97.72
24-Stunden-Volumen:
1.26M
Relative Volume:
0.14
Marktkapitalisierung:
$248.54B
Einnahmen:
$63.17B
Nettoeinkommen (Verlust:
$12.15B
KGV:
53.93
EPS:
1.8
Netto-Cashflow:
$14.84B
1W Leistung:
-1.30%
1M Leistung:
-8.71%
6M Leistung:
-25.76%
1J Leistung:
-5.02%
1-Tages-Spanne:
$97.00
$98.43
1-Wochen-Bereich:
$94.48
$98.84
52-Wochen-Spanne:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| MRK | 97.03 | 248.54B | 63.17B | 12.15B | 14.84B | 1.80 |
| LLY | 739.52 | 693.54B | 40.86B | 8.37B | -2.28B | 5.4193 |
| NVO | 101.82 | 465.74B | 39.36B | 13.79B | 9.83B | 2.4077 |
| JNJ | 153.13 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
| ABBV | 167.56 | 294.70B | 55.53B | 5.12B | 15.62B | 3.65 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Integrated Investment Consultants LLC - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Trustmark National Bank Trust Department - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 142,958 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Intech Investment Management LLC Raises Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
King Luther Capital Management Corp Purchases 44,795 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Citizens Financial Group Inc. RI Has $27.79 Million Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Ontario Teachers Pension Plan Board Sells 7,664 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jennison Associates LLC Sells 728,756 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care - Yahoo Finance
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio - Insider Monkey
Payden & Rygel Grows Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Moran Wealth Management LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Grandfield & Dodd LLC - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Sells 792,148 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Commerce Bank Buys 29,422 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Private Wealth LLC Buys 12,781 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Cut by Northwest Bancshares Inc. - MarketBeat
Strategy Asset Managers LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Quest Partners LLC Has $1.18 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck says Keytruda injection on par with approved IV version in trial - Reuters
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co.’s Subcutaneous Keytruda Matches I.V. - Citeline News & Insights
Merck & Co., Inc. (NYSE:MRK) Raises Dividend to $0.81 Per Share - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.1%Here's Why - MarketBeat
Merck readies new Keytruda version ahead of major regulatory headwinds - Seeking Alpha
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients - Yahoo Finance
Merck & Co. Raises Quarterly Dividend by 5.2% - Marketscreener.com
Merck Increases Quarterly Dividend to $0.81 Per Share, Payable Jan. 8 to Shareholders of Record Dec. 16 - Marketscreener.com
Merck Declares $0.81 Per Share Q1 2025 Dividend, Sets January Payment Date | MRK Stock News - StockTitan
New Millennium Group LLC Has $1.27 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
PNC Financial Services Group Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Makes New $42.43 Million Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: success of a subcutaneous version of Keytruda - Marketscreener.com
Fifth Third Wealth Advisors LLC Buys 34,312 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Prospera Financial Services Inc Purchases 9,387 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Boosted by Smead Capital Management Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Meeder Asset Management Inc. - MarketBeat
Merck stock gains on injectable Keytruda trial win (MRK:NYSE) - Seeking Alpha
Pathstone Holdings LLC Sells 7,059 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Belmont Capital LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’ - Insider Monkey
Merck & Co. Inc. stock rises Monday, still underperforms market - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.6%What's Next? - MarketBeat
Stocks Flash: Biggest Recent Disappointment (Merck & Co Inc., MRK) and Biggest Bright Spot (Dell Technologies Inc, DELL) - Elliott Wave International
Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now? - Insider Monkey
Braun Stacey Associates Inc. Sells 7,853 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
AMG National Trust Bank Sells 5,505 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Aljian Capital Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by TrinityPoint Wealth LLC - MarketBeat
Swiss National Bank Has $853.74 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Thrivent Financial for Lutherans Has $208.65 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):